gamine xr
aspen pharma pty ltd - galantamine hydrobromide -
galantamine an sr galantamine (as hydrobromide) 8mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide -
galantamine an sr galantamine (as hydrobromide) 24mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide -
galantamine an sr galantamine (as hydrobromide) 16mg modified release capsules blister pack
southern cross pharma pty ltd - galantamine hydrobromide -
gamine xr galantamine (as hydrobromide) 24mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: indigo carmine; iron oxide red; erythrosine; gelatin; hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; microcrystalline cellulose; ethylcellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
gamine xr galantamine (as hydrobromide) 16mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; titanium dioxide; microcrystalline cellulose; iron oxide red; magnesium stearate; hypromellose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
gamine xr galantamine (as hydrobromide) 8mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: hypromellose; gelatin; magnesium stearate; microcrystalline cellulose; ethylcellulose; titanium dioxide - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
reminyl
janssen-cilag pty ltd - galantamine -
reminyl galantamine 24mg (as hydrobromide) modified release capsule
janssen-cilag pty ltd - galantamine hydrobromide, quantity: 30.76 mg (equivalent: galantamine, qty 24 mg); galantamine, quantity: 24 mg (equivalent: galantamine hydrobromide, qty 30.76 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; diethyl phthalate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid; potassium hydroxide; titanium dioxide; iron oxide yellow; sorbitan monolaurate; iron oxide red; gelatin; sodium lauryl sulfate; macrogol 400; maize starch; sucrose - indicated for the treatment of mild to moderately severe dementia of the alzheimer type.
reminyl galantamine 16mg (as hydrobromide) modified release capsule
janssen-cilag pty ltd - galantamine hydrobromide, quantity: 20.51 mg (equivalent: galantamine, qty 16 mg); galantamine, quantity: 16 mg (equivalent: galantamine hydrobromide, qty 20.51 mg) - capsule, modified release - excipient ingredients: diethyl phthalate; ethylcellulose; hypromellose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; maize starch; sucrose; macrogol 400; titanium dioxide; sorbitan monolaurate; iron oxide red; gelatin; sodium lauryl sulfate; ethanol absolute; sulfuric acid - indicated for the treatment of mild to moderately severe dementia of the alzheimer type.